Compound Detail
CHEMBL3265032
ENTOSPLETINIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL3265032 |
| Name | ENTOSPLETINIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | XSMSNFMDVXXHGJ-UHFFFAOYSA-N |
15
Targets
36
Activities
2
Assay Types
11
PK Parameters
20
Publications
3
Known Names
9
Indications
1
Mechanisms
Molecular Properties
411.5
MW (Da)
3.85
ALogP
7
HBA
2
HBD
83.4
PSA (Ų)
0.47
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tyrosine-protein kinase SYK inhibitor | INHIBITOR | Tyrosine-protein kinase SYK | ✓ | ✓ |
Indications
Leukemia, Myeloid, Acute Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell Lymphoma, Non-Hodgkin Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma
Activity Summary
IC50 26 meas. best 8.11
EC50 10 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase SYK CHEMBL2599 | EC50 | 8.7 | 7.2917 | 2.0 | 6 |
| Tyrosine-protein kinase SYK CHEMBL2599 | IC50 | 8.11 | 7.2508 | 7.7 | 13 |
| BaF3 CHEMBL614524 | IC50 | 7.5 | 6.375 | 32.0 | 2 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | IC50 | 6.84 | 6.84 | 143.0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 6.52 | 6.52 | 303.0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | EC50 | 6.49 | 6.49 | 327.0 | 1 |
| Mast/stem cell growth factor receptor Kit CHEMBL2034798 | EC50 | 6.35 | 6.35 | 445.0 | 1 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | EC50 | 6.34 | 6.34 | 453.0 | 1 |
| High affinity nerve growth factor receptor CHEMBL2815 | IC50 | 6.25 | 6.25 | 569.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 6.24 | 6.24 | 582.0 | 1 |
| Casein kinase 2 CHEMBL3832943 | IC50 | 6.22 | 6.22 | 604.0 | 1 |
| Tyrosine-protein kinase BTK CHEMBL5251 | IC50 | 6.1 | 6.1 | 801.0 | 1 |
| Protein-tyrosine kinase 6 CHEMBL4601 | IC50 | 6.08 | 6.08 | 842.0 | 1 |
| Proto-oncogene tyrosine-protein kinase ROS CHEMBL5568 | IC50 | 6.07 | 6.07 | 857.0 | 1 |
| Tyrosine-protein kinase SYK CHEMBL4364 | EC50 | 5.72 | 5.72 | 1900.0 | 1 |
| NCI-H1299 CHEMBL612255 | IC50 | 5.2 | 5.2 | 6260.0 | 1 |
| Caco-2 CHEMBL614058 | IC50 | 5.16 | 5.16 | 6860.0 | 1 |
| OVCAR-5 CHEMBL614214 | IC50 | 5.08 | 5.08 | 8300.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 4.5 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 13.33 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 6.833 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.167 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.167 | mL.min-1.kg-1 | Homo sapiens |
| F | 67.0 | % | Rattus norvegicus |
| F | 53.0 | % | Canis lupus familiaris |
| Fu | 0.027 | - | Homo sapiens |
| T1/2 | 0.5833 | hr | Rattus norvegicus |
| T1/2 | 0.39 | hr | Canis lupus familiaris |
| T1/2 | 1.643 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine